Lahiri Rajiv, Derwa Yannick, Bashir Zora, Giles Edward, Torrance Hew D T, Owen Helen C, O'Dwyer Michael J, O'Brien Alastair, Stagg Andrew J, Bhattacharya Satyajit, Foster Graham R, Alazawi William
*Blizard Institute, Queen Mary University of London, London, United Kingdom †Barts Health HPB Centre, Royal London Hospital, London, United Kingdom ‡William Harvey Research Institute, Queen Mary University of London, London, United Kingdom §University College London, London, United Kingdom.
Ann Surg. 2016 May;263(5):1028-37. doi: 10.1097/SLA.0000000000001248.
To study innate immune pathways in patients undergoing hepatopancreaticobiliary surgery to understand mechanisms leading to enhanced inflammatory responses and identifying biomarkers of adverse clinical consequences.
Patients undergoing major abdominal surgery are at risk of life-threatening systemic inflammatory response syndrome (SIRS) and sepsis. Early identification of at-risk patients would allow tailored postoperative care and improve survival.
Two separate cohorts of patients undergoing major hepatopancreaticobiliary surgery were studied (combined n = 69). Bloods were taken preoperatively, on day 1 and day 2 postoperatively. Peripheral blood mononuclear cells and serum were separated and immune phenotype and function assessed ex vivo.
Early innate immune dysfunction was evident in 12 patients who subsequently developed SIRS (postoperative day 6) compared with 27 who did not, when no clinical evidence of SIRS was apparent (preoperatively or days 1 and 2). Serum interleukin (IL)-6 concentration and monocyte Toll-like receptor (TLR)/NF-κB/IL-6 functional pathways were significantly upregulated and overactive in patients who developed SIRS (P < 0.0001). Interferon α-mediated STAT1 phosphorylation was higher preoperatively in patients who developed SIRS. Increased TLR4 and TLR5 gene expression in whole blood was demonstrated in a separate validation cohort of 30 patients undergoing similar surgery. Expression of TLR4/5 on monocytes, particularly intermediate CD14CD16 monocytes, on day 1 or 2 predicted SIRS with accuracy 0.89 to 1.0 (areas under receiver operator curves).
These data demonstrate the mechanism for IL-6 overproduction in patients who develop postoperative SIRS and identify markers that predict patients at risk of SIRS 5 days before the onset of clinical signs.
研究接受肝胰胆手术患者的固有免疫途径,以了解导致炎症反应增强的机制,并确定不良临床后果的生物标志物。
接受大腹部手术的患者有发生危及生命的全身炎症反应综合征(SIRS)和脓毒症的风险。早期识别高危患者将有助于进行针对性的术后护理并提高生存率。
对两组分别接受大肝胰胆手术的患者进行了研究(共69例)。术前、术后第1天和第2天采集血液。分离外周血单核细胞和血清,并在体外评估免疫表型和功能。
与27例未发生SIRS的患者相比,12例随后发生SIRS(术后第6天)的患者早期固有免疫功能障碍明显,而在术前或术后第1天和第2天未出现SIRS的临床证据。发生SIRS的患者血清白细胞介素(IL)-6浓度以及单核细胞Toll样受体(TLR)/核因子κB/IL-6功能途径显著上调且过度活跃(P<0.0001)。发生SIRS的患者术前干扰素α介导的信号转导和转录激活因子1(STAT1)磷酸化水平更高。在另一组30例接受类似手术的验证队列中,全血中TLR4和TLR5基因表达增加。第1天或第2天单核细胞上TLR4/5的表达,尤其是中间型CD14CD16单核细胞上的表达,预测SIRS的准确率为0.89至1.0(受试者操作特征曲线下面积)。
这些数据证明了术后发生SIRS的患者IL-6过度产生的机制,并确定了在临床症状出现前5天预测有SIRS风险患者的标志物。